CHE
Chemed Corporation · Healthcare · Medical - Care Facilities
Señales de momentum (gestores comparables):
amplitud de titulares +5.0% ·
flujo de acciones +1.4% ·
nuevas posiciones netas +4.8%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | +1 | 53.78K | $26.72M | +1 | n/a |
| Q2 2026 | 131 | +6 | 8.89M | $4.13B | +9 | −4 |
| Q1 2026 | 129 | 0 | 8.71M | $3.29B | +5 | −6 |
| Q4 2025 | 129 | -2 | 9.90M | $4.23B | +1 | −2 |
| Q3 2025 | 22 | -1 | 5.87M | $2.63B | n/a | −2 |
| Q2 2025 | 21 | +1 | 4.75M | $2.31B | +2 | −1 |
| Q1 2025 | 17 | 0 | 1.55M | $954.33M | +1 | −1 |
| Q4 2024 | 17 | +1 | 1.54M | $817.61M | +2 | −1 |
| Q3 2024 | 15 | 0 | 874.91K | $525.85M | n/a | n/a |
| Q2 2024 | 15 | n/a | 976.21K | $529.86M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 1.60M | n/a | $780.34M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasivo) | 1.34M | n/a | $651.94M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 3 | State Street Global Advisors ✦ (pasivo) | 477.01K | -1.7% | $232.27M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 355.81K | -0.1% | $173.27M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | AQR Capital Management ✦ | 201.04K | +160.9% | $97.89M | 0.1% | ▲ Add | 5 | SEC ↗ ×5 |
| 6 | Fidelity (FMR) ✦ | 188.82K | n/a | $91.94M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 7 | Norges Bank ✦ (pasivo) | 183.57K | -8.6% | $89.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Millennium Management ✦ | 134.78K | +87.5% | $65.63M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 88.50K | +73.2% | $43.09M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 40.13K | -8.1% | $19.54M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 11 | Two Sigma Investments ✦ | 36.03K | +869.3% | $17.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 21.24K | -6.9% | $10.34M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | GAMCO Investors ✦ | 20.28K | +1.9% | $9.87M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 16.74K | -65.3% | $8.15M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | Arrowstreet Capital ✦ | 11.37K | +67.0% | $5.53M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 10.20K | -31.8% | $4.97M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 9.76K | -15.0% | $4.75M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 4.50K | Nuevo | $2.19M | 0.0% | New | 1 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 2.84K | -63.0% | $1.38M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Wellington Management ✦ | 1.97K | -2.3% | $957,791 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Marshall Wace ✦ | 1.19K | Nuevo | $579,448 | 0.0% | New | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Adage Capital Partners | $2.19M | 0.0% |
| Marshall Wace | $579,448 | 0.0% |
Posición cerrada
| Point72 Asset Management | $79.18M | era 0.2% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 486 tenedores, 12.67M acciones, $4.47B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 2.00K acc. · $1.03M
Officer, Director · 2.00K acc. · $1.00M
Officer, Director · 2.00K acc. · $1.08M
Officer · 1.00K acc. · $541,040
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología